EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active substance Bimekizumab, ATC L04AC21 for the period 01.10.2026 - 31.03.2027
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bimekizumab, ATC L04AC21 für die Zeit 01.10.2026 - 31.03.2027
Wanted: Pharmaceutical products. The tender is called “Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active substance Bimekizumab, ATC L04AC21 for the period 01.10.2026 - 31.03.2027”. The deadline for offers is Friday, 5 February 2027, in 96 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 February 2027, 96 days left, 12:00
- Published
- 18 August 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
DAK-Gesundheit is concluding a discount agreement for medicinal products containing the active substance Bimekizumab.
- The contract period is from October 2026 to March 2027.
- Pharmaceutical companies can join at any time.
- Offers must be submitted by email.
- Documents for joining must be received by the 5th of the preceding month.
- The contract ends upon the conclusion of an exclusive contract.
Summary made from the German notice and checked against it; the German original is authoritative.
Conditions stated in the notice
| Duration | 6 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
What stands out
The notice links the tender documents directly. The contract runs for 6 months.
Questions and answers
When is the deadline for offers?
Until Friday, 5 February 2027, 96 days left. The exact time and how to submit are in the original notice, which is authoritative.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Timeline
| Published | Tuesday, 18 August 2026 |
|---|---|
| Deadline | Friday, 5 February 2027, 12:00 |
| Tender validity ends (calculated) | Sunday, 7 March 2027 |
Service by CPV code
- 33600000 Pharmaceutical products
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.